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These results suggest that antibiotic use, specifically vancomycin, promotes persistent gastrointestinal colonization with VRE. Pulsed-field gel electrophoresis results in patients with an intermittent pattern of VRE colonization demonstrated that, in one half of the patients, the same isolate persisted despite the three negative cultures over 3 weeks. While this could be due to inadequate sampling, it more likely was due to persistent colonization at levels too low to be detected by culture until the use of antibiotics promoted the growth of VRE again. Healthcare workers are estimated to be at a fourfold higher risk of infection with hepatitis B virus (HBV) than the general population. 1 The HBV vaccine is highly effective, but cost is an important factor that affects implementation of immunization programs. In highly endemic areas, prescreening may reduce costs by avoiding unnecessar y vaccination. We studied the HBV profile of our healthcare workers with the aim of determining the cost-effectiveness of prevaccination screening.
METHODS
We studied 572 healthcare workers at Aga Khan University Hospital, a large university medical center. Initially, both hepatitis B surface antigen (HBsAg) and antibody (HBsAb) were tested by enzymelinked immunosorbent assay (Abbott Laboratories, Chicago, IL). However, as the prevalence rates of HBsAg were low, subsequent screening was done only for HBsAb to curtail costs. The clinical areas sur veyed are shown in the Table. The current cost of HBsAb in our laboratory is $8 (US) and that of three doses of Engerix B vaccine (SmithKline Beecham, Philadelphia, PA) is $30. Prescreening costeffectiveness was determined using the following formula for the prevalence of HBsAb above which screening is cost-effective:
where CV=cost of vaccine and CT=cost of test. This readily derived formula identifies the seroprevalence rates above which the cost of screening and vaccination would be lower than the cost of vaccination alone, whereas previously described calculations have used the cost of screening to determine cost-effectiveness. 2
RESULTS
Three of 80 (3.75%) employees tested positive for HBsAg, while 87 of 572 (15.2%) were HBsAb-positive. Areas of highest seroprevalence (>20%) were the Labor and Emergency Rooms, Anesthesiology, and Clinical Laboratory (Table) ; however, rates by department did not differ significantly (chi-squared, 13.37 with 14 df; P=.50).
Using our formula, we calculated that it would be cost-effective to prescreen in our institution only if the expected HBsAb prevalence rate was at least 26.7%. Therefore, screening would not have been cost-effective in our hospital.
DISCUSSION
Hepatitis B is endemic in Pakistan, with seroprevalence rates of 6% to 8% for HBsAg and 25% to 30% for HBsAb. 3 We found lower seroprevalence rates in our healthcare workers compared to the general population. The reasons for this are unclear but may relate to educational background or economic class.
We found that it would be not be cost-effective for our institution to prescreen our employees before HBV vaccination. Therefore, we recommended direct vaccination of all our employees, particularly as there are no adverse effects of vaccination in 
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